Oxford Science Enterprises
Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI &a; software, and deep tech.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Oxford Science Enterprises Information
Geographic Data
Address: 46 Woodstock Road
City: Oxford
State: england
Zip: OX2 6HT
Country: GB
Financial Info
Stage:
Raised Last:
$299M
Raised Total:$300M
Social
Twitter
Linkedin
Crunchbase
Metrics
4,299,602Website Global Rank
2,884Website Monthly Traffic
Twitter Followers
Description
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2021 | ONI | Series B | 75M |
| 12/2016 | Circadian Therapeutics | Venture Round | 2.5M |
| 6/2015 | OxStem | Seed Round | - |
| 6/2018 | Metaboards | Series A | 0 |
| 7/2020 | PQShield | Seed Round | 6.9M |
| 4/2018 | Oxford Flow | Venture Round | 8.5M |
| 7/2016 | Oxford Impedance Diagnostics Ltd. | Seed Round | 2.6M |
| 1/2021 | Living Optics | Seed Round | 0 |
| 5/2018 | Orbit Discovery | Series A | 0 |
| 11/2017 | First Light Fusion | Venture Round | - |
| 1/2017 | Oxford VR | Seed Round | - |
| 10/2018 | Animal Dynamics | Series A | 0 |
| 5/2018 | Ultromics | Series A | 0 |
| 6/2022 | BibliU | Series B | 0 |
| 9/2018 | Evox Therapeutics | Series B | 0 |
| 12/2021 | Navenio | Venture Round | 0 |
| 7/2019 | Zegami | Series B | 1.6M |
| 7/2021 | Rey | Series A | 10M |
| 4/2023 | Caristo Diagnostics | Series A | 0 |
| 3/2023 | Mixergy | Venture Round | 0 |
| 3/2023 | Quantrol Ox | Seed Round | 0 |
| 2/2023 | Archangel Lightworks | Seed Round | 0 |
| 12/2022 | BehaVR | Series B | 0 |
| 6/2018 | BibliU | Seed Round | 3.8M |
| 3/2018 | Xerion Healthcare | Venture Round | 2.8M |
| 3/2022 | Scenic Biotech | Series A | 0 |
| 1/2017 | Covatic | Seed Round | 896.6k |
| 3/2021 | Caristo Diagnostics | Venture Round | - |
| 2/2017 | BibliU | Seed Round | 1.4M |
| 7/2018 | ONI | Series A | 24M |
| 2/2020 | Oxford VR | Series A | 0 |
| 10/2018 | Caristo Diagnostics | Seed Round | 2.6M |
| 8/2019 | MoA Technology | Series A | 7.6M |
| 11/2022 | Util | Seed Round | 0 |
| 6/2020 | Base Genomics | Seed Round | 11.3M |
| 1/2023 | Grey Wolf Therapeutics | Series B | 0 |
| 6/2023 | Beacon Therapeutics | Series A | 0 |
| 5/2018 | Opsydia | Seed Round | 2.5M |
| 2/2018 | Odqa Renewable Energy Technologies | Seed Round | 570.6k |
| 12/2019 | Mixergy Ltd. | Series A | 0 |
| 9/2022 | Opsydia | Venture Round | 0 |
| 10/2019 | MiroBio | Series A | 33.2M |
| 5/2016 | ONI | Seed Round | 1.7M |
| 7/2020 | ORCA Computing | Pre Seed Round | - |
| 6/2020 | Oxford Flow | Venture Round | 0 |
| 8/2017 | Inkpath | Series A | - |
| 6/2022 | MiroBio | Series B | 0 |
| 5/2018 | PQShield | Seed Round | - |
| 2/2021 | Evox Therapeutics | Series C | 96.7M |
| 2/2018 | Latent Logic | Seed Round | 2M |
| 4/2020 | Perspectum | Series B | 35.9M |
| 3/2021 | Vaccitech | Series B | 168M |
| 5/2018 | Util | Seed Round | 1.1M |
| 10/2018 | Covatic | Seed Round | 1.1M |
| 1/2023 | Amber Therapeutics | Seed Round | - |
| 12/2020 | DJS Antibodies | Venture Round | 0 |
| 3/2017 | Bodle Technologies | Seed Round | - |
| 6/2015 | Proxisense | Seed Round | - |
| 11/2017 | Albus Health | Convertible Note | 66.6k |
| 6/2019 | Oxford Semantic Technologies | Series A | 3.8M |
| 9/2016 | Iota Sciences | Seed Round | - |
| 6/2017 | Diffblue | Series A | 21.8M |
| 1/2022 | PQShield | Series A | 0 |
| 8/2021 | Pepgen | Venture Round | 0 |
| 11/2018 | OMass Technologies | Series A | 17.9M |
| 12/2020 | Pepgen | Series A | 45M |
| 12/2015 | Navenio | Seed Round | 2.6M |
| 5/2022 | Salience Labs | Seed Round | 11.5M |
| 7/2022 | Brill Power | Series A | 0 |
| 3/2017 | SpyBiotech | Seed Round | 5M |
| 1/2018 | Bodle Technologies | Series A | 8.5M |
| 6/2016 | OMass Technologies | Seed Round | 1.4M |
| 12/2020 | T-Cypher Bio | Seed Round | - |
| 2/2020 | OMass Technologies | Series A | 35.8M |
| 1/2023 | Oxford Ionics | Series A | 0 |
| 1/2021 | Theolytics | Series A | 6.8M |
| 9/2011 | Oxtex | Seed Round | 800k |
| 2/2016 | Mind Foundry | Seed Round | 1.7M |
| 1/2018 | Vaccitech | Series A | 0 |
| 11/2022 | Osler Diagnostics | Series C | 0 |
| 9/2017 | Oxford Quantum Circuits | Series A | - |
| 4/2017 | ONI | Seed Round | 3.7M |
| 11/2018 | OxMet Technologies | Series A | 7.8M |
| 6/2017 | Zegami | Series A | 3M |
| 10/2022 | Nucleome Therapeutics | Series A | 42.3M |
| 9/2018 | Oxford VR | Seed Round | 4.2M |
| 4/2020 | Living Optics | Seed Round | 4.1M |
| 3/2017 | Pro-Mapp | Seed Round | - |
| 5/2022 | MoA Technology | Series B | 0 |
| 3/2018 | 6D.ai | Seed Round | - |
| 9/2017 | Mind Foundry | Seed Round | 3.4M |
| 8/2018 | Genomics | Series B | 32.5M |
| 8/2021 | Ultromics | Series B | 0 |
| 4/2021 | Oxford Endovascular | Series A | 0 |
| 2/2021 | SpyBiotech | Series A | 32.5M |
| 9/2019 | YASA | Series C | 22.2M |
| 11/2020 | Refeyn | Series A | 30M |
| 12/2017 | Navenio | Funding Round | 7.7M |
| 2/2023 | Quantum Motion | Series B | 0 |
| 5/2020 | Navenio | Series A | 0 |
| 8/2018 | BioBeats | Seed Round | 3M |
| 5/2020 | Quantum Motion Technologies | Series A | 9.8M |
| 12/2017 | Theolytics | Seed Round | 3.4M |
| 4/2022 | OMass Technologies | Series B | 0 |
| 11/2016 | Vaccitech | Seed Round | 12.4M |
| 5/2017 | Ultromics | Seed Round | 2.6M |
| 8/2017 | OxMet Technologies | Seed Round | 2.6M |
| 2/2022 | First Light Fusion | Series C | 45M |
| 12/2021 | Alethiomics | Seed Round | 8M |
| 5/2016 | Evox Therapeutics | Series A | 14.4M |
| 6/2020 | Oxford Ionics | Seed Round | 3.4M |
| 10/2016 | DJS Antibodies | Seed Round | - |
| 12/2016 | EnzBond | Seed Round | 445.3k |
| 1/2016 | Oxford Flow | Seed Round | - |
| 6/2022 | ORCA Computing | Series A | 15M |
| 5/2019 | Albus Health | Convertible Note | 580.9k |
| 3/2016 | Diffblue | Seed Round | - |
| 3/2017 | Oxford Semantic Technologies | Seed Round | - |
| 7/2022 | Oxford Quantum Circuits | Series A | 45.4M |
| 8/2018 | Edplus | Pre Seed Round | 643.5k |
| 9/2018 | Oxford VR | Venture Round | 4.2M |
| 6/2017 | Scenic Biotech | Series A | 7.3M |
| 12/2018 | Genomics | Series B | 9.1M |
| 5/2021 | Omega Crop | Seed Round | 1.7M |
| 1/2018 | Pepgen | Seed Round | - |
| 1/2016 | Mixergy Ltd. | Seed Round | - |
| 3/2021 | Genomics | Venture Round | 30M |
| 1/2020 | OxMet Technologies | Series B | 14.1M |
| 10/2016 | Argonaut Therapeutics | Seed Round | - |
| 11/2017 | Quantum Motion Technologies | Seed Round | - |
| 11/2015 | Bodle Technologies | Seed Round | - |
| 7/2019 | Zegami | Series B | 1.6M |
| 7/2021 | Orbit Discovery | Venture Round | 0 |
| 4/2020 | BibliU | Series A | 10M |
| 4/2023 | Caristo Diagnostics | Series A | 0 |
| 3/2023 | Mixergy | Venture Round | 0 |
| 3/2023 | Quantrol Ox | Seed Round | 0 |
| 2/2023 | Quantum Motion | Series B | 0 |
| 2/2023 | Archangel Lightworks | Seed Round | 0 |
| 1/2023 | Grey Wolf Therapeutics | Series B | 0 |
| 1/2023 | Amber Therapeutics | Seed Round | - |
| 1/2023 | Oxford Ionics | Series A | 0 |
| 12/2022 | BehaVR | Series B | 0 |
| 11/2022 | Osler Diagnostics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
